ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 242 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,672,794 | -3.4% | 203,409 | -7.4% | 0.10% | -5.7% |
| Q2 2023 | $2,767,703 | +56.7% | 219,659 | +62.3% | 0.10% | +41.9% |
| Q1 2023 | $1,766,513 | +91.0% | 135,365 | +158.2% | 0.07% | +32.1% |
| Q4 2022 | $924,724 | +227.9% | 52,422 | +318.4% | 0.06% | +409.1% |
| Q1 2022 | $282,000 | -58.0% | 12,530 | -65.6% | 0.01% | -63.3% |
| Q4 2021 | $672,000 | -16.3% | 36,449 | -39.3% | 0.03% | -34.8% |
| Q3 2021 | $803,000 | -51.8% | 60,083 | -45.8% | 0.05% | -43.9% |
| Q1 2021 | $1,665,000 | +191.1% | 110,902 | +57.8% | 0.08% | +203.7% |
| Q3 2020 | $572,000 | -73.6% | 70,260 | -78.0% | 0.03% | -75.5% |
| Q2 2020 | $2,163,000 | +54.2% | 319,488 | +60.3% | 0.11% | +8.9% |
| Q1 2020 | $1,403,000 | -15.7% | 199,279 | +17.6% | 0.10% | +38.4% |
| Q4 2019 | $1,664,000 | -46.0% | 169,520 | -39.6% | 0.07% | -53.5% |
| Q3 2019 | $3,082,000 | +185.1% | 280,684 | +202.0% | 0.16% | +161.7% |
| Q2 2019 | $1,081,000 | -64.3% | 92,933 | -70.7% | 0.06% | -67.2% |
| Q1 2019 | $3,027,000 | +332.4% | 317,323 | +336.9% | 0.18% | +226.8% |
| Q4 2018 | $700,000 | -66.1% | 72,627 | -49.9% | 0.06% | -64.8% |
| Q3 2018 | $2,067,000 | -8.9% | 145,038 | -23.3% | 0.16% | -10.2% |
| Q2 2018 | $2,268,000 | +72.2% | 188,975 | +77.2% | 0.18% | +101.1% |
| Q1 2018 | $1,317,000 | -33.1% | 106,624 | -21.2% | 0.09% | -34.8% |
| Q4 2017 | $1,969,000 | -40.4% | 135,299 | -41.7% | 0.14% | -51.4% |
| Q3 2017 | $3,302,000 | +24.3% | 232,012 | +11.4% | 0.28% | +16.3% |
| Q2 2017 | $2,657,000 | +464.1% | 208,203 | +460.9% | 0.24% | +408.5% |
| Q1 2017 | $471,000 | -75.3% | 37,119 | -74.3% | 0.05% | -76.3% |
| Q3 2016 | $1,904,000 | -43.3% | 144,575 | -45.3% | 0.20% | -17.8% |
| Q2 2016 | $3,356,000 | +1984.5% | 264,217 | +2074.1% | 0.24% | +1753.8% |
| Q1 2016 | $161,000 | -86.7% | 12,153 | -86.3% | 0.01% | -89.0% |
| Q2 2015 | $1,210,000 | +7.4% | 88,453 | -6.2% | 0.12% | -21.3% |
| Q1 2015 | $1,127,000 | +198.9% | 94,257 | +219.0% | 0.15% | +40.2% |
| Q4 2014 | $377,000 | – | 29,552 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |